ConductScience.org, home

Paper31969331

ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases.

Kumthekar P and 15 others. Clin Cancer Res, 2020. Cited by 207 papers, by iCite.

Cite this record

ConductScience Library. ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases. Papers, record 31969331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31969331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2020
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
207
iCite
Relative citation ratio, by iCite
10.1
iCite
Revised in PubMed
2024-05-25
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumthekar PPriya
2Tang SCShou-Ching
3Brenner AJAndrew Jhttps://orcid.org/0000-0002-3985-253X
4Kesari SSantosh
5Piccioni DEDavid E
6Anders CCarey
7Carrillo JJose
8Chalasani PPavani
9Kabos PPeter
10Puhalla SShannon
11Tkaczuk KKatherinehttps://orcid.org/0000-0002-5978-5215
12Garcia AAAgustin Ahttps://orcid.org/0000-0002-5431-5329
13Ahluwalia MSManmeet S
14Wefel JSJeffrey S
15Lakhani NNehal
16Ibrahim NNuhad

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Breast NeoplasmsMajor topic
Meningeal CarcinomatosisMajor topic
Neoplasm Recurrence, LocalMajor topic
PaclitaxelMajor topic
PeptidesMajor topic
Adult
Aged
Female
Follow-Up Studies
Humans
Middle Aged
Prognosis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30CA023074NIH

Source NIH RePORTER

Download CSV of grants

Cited by137

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.

PMIDTitleJournalYearIn PapersSource
42751312Boron-embedded multifunctional nanoplatform toward potential combined boron neutron capture therapy and immunomodulation in glioma.Smart Mol2026https://conductscience.org/library/papers/42751312PubMed
42744036Therapeutic potential of colchicine-binding site inhibitors in breast cancer brain metastasis.Cancer Lett2026https://conductscience.org/library/papers/42744036PubMed
42639267RNA-Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities.MedComm (2020)2026https://conductscience.org/library/papers/42639267PubMed
42575968Protein-protein interaction-mediated signaling networks in ischemic stroke: from molecular mechanisms to therapeutic strategies.Acta Pharmacol Sin2026https://conductscience.org/library/papers/42575968PubMed
42559290Antibody-Drug Conjugates and Peptide-Drug Conjugates: Current Understandings and Future Perspectives.MedComm (2020)2026https://conductscience.org/library/papers/42559290PubMed
42395902Anti-SARS-CoV-2 VHH and C7C peptide fused with Angiopep-2 efficiently traverse blood-brain barrier model and neutralizes virus.Front Microbiol2026https://conductscience.org/library/papers/42395902PubMed
42262659Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progress.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42262659PubMed
42196473Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.Int J Mol Sci2026https://conductscience.org/library/papers/42196473PubMed
41938756HR+/HER2- breast cancer brain metastases treated with definitive local therapy: a focus on endocrine sensitivity and incidence of leptomeningeal disease.Neurooncol Adv2026https://conductscience.org/library/papers/41938756PubMed
41938171Blood-Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems.MedComm (2020)2026https://conductscience.org/library/papers/41938171PubMed
41836468Peptides as multifunctional linchpins in targeted drug conjugates.RSC Med Chem2026https://conductscience.org/library/papers/41836468PubMed
41828617When 'Dirty' Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs.Int J Mol Sci2026https://conductscience.org/library/papers/41828617PubMed
41710577Tumor Targeting with Peptide-Drug Conjugates: Showcasing Key Progress and Hurdles.Drug Des Devel Ther2026https://conductscience.org/library/papers/41710577PubMed
41660126Advancing precision tumor therapy: Progress in targeted delivery of peptide-based nanomaterials from microenvironment to organelles.Mater Today Bio2026https://conductscience.org/library/papers/41660126PubMed
41654916Bridging the blood-brain barrier: strategies to improve delivery of biologics to tumors in the brain.Fluids Barriers CNS2026https://conductscience.org/library/papers/41654916PubMed
41594569From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy.Biomolecules2025https://conductscience.org/library/papers/41594569PubMed
41425250Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies.Cancer Drug Resist2025https://conductscience.org/library/papers/41425250PubMed
41345392Cancer cell-monocyte co-culture spheroids recapitulate pro-tumorigenic, immunosuppressive, and drug-resistant microenvironments in brain metastatic breast cancer.NPJ Breast Cancer2025https://conductscience.org/library/papers/41345392PubMed
41001098The Peptide-Drug Conjugate M1pep-Tasquinimod Ameliorates Acute Pancreatitis via Selectively Clearing M1-like Macrophages.Biomater Res2025https://conductscience.org/library/papers/41001098PubMed
40907474Novel approaches to clinical trial design in cancer neuroscience.Neuron2025https://conductscience.org/library/papers/40907474PubMed

See all 137 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
LRP14035PubTator's text mininghttps://conductscience.org/library/genes/4035

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31969331

GET https://conductscience.org/api/papers/v1/31969331/cited_by?page=2